drugset / Trial / NCT02041299
Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias
RandomizedParallel-groupOpen-labelTreatment
Summary
This research is being done so that we can look at the safety and efficacy of deferiprone in people with sickle cell disease or other anemias. Deferiprone is a drug that removes iron from the body. We will be comparing deferiprone with deferoxamine, another drug that removes iron from the body.
Timeline
- Start
- 2014-04-17
- Primary completion
- 2019-04-20
- Completion
- 2019-06-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Deferiprone | Small molecule | 25 mg/kg | Oral |
| Subject | Deferiprone | Small molecule | 33 mg/kg | Oral |
| Comparator | Deferoxamine | Other / unclassified | 20 mg/kg | Subcutaneous |
| Comparator | Deferoxamine | Other / unclassified | 40 mg/kg | Subcutaneous |
| Comparator | Deferoxamine | Other / unclassified | 50 mg/kg | Subcutaneous |